incidence of carcinoma of the prostate and chronic lymphatic leukemia in the Japanese and Chinese; and it would not be surprising if genetic factors turned out to be the explanation for any or all of these observations. The high incidence of nasopharyngeal carcinoma in the Chinese, particularly the southern Chinese, has often been thought to be a genetic characteristic but this is, perhaps, less likely now that a relatively high incidence has also been observed among Africans in central Kenya.
That genetic factors are not the explanation for many of the major differences is demonstrated conclusively by the effects of migration. Negroes in the United States, Japanese in Hawaii, and Englishmen in Australia rapidly lose the risks that are characteristic of their home countries and take on the pattern of cancer distribution that is characteristic of the country in which they live. From the totality of the evidence there seems little doubt that the greater part of all cancer is, in principle, preventableat least while the modal span of life is kept down to something under 90 years. Whether it will be possible to prevent cancer, due, perhaps, to factors such as the natural radioactivity of the body, at much older ages remains to be seen. Burkitt D P, Hutt'M S R & Slavin G (1968) Brit. J. Cancer 22, 1 Collis C H, Cook P, Foreman J K & Palframan J F (1971) Gut 12, 1015 Cook P (1972) Brit. J. Cancer (in press) Cook P J & Burkitt D P (1971) Brit, med. Bull. 27,14 DoU R (1969) Brit. J. Cancer 23, 1 (1971)J. roy. statist. Soc. A. 34, 133 Doll R & Cook P (1967) The advances of the last two decades in the field of polypeptide hormones have resulted in the discovery of hormone production by tumours arising from tissues other than the appropriate endocrine organs. A variety of such 'ectopic' hormones are now known to be produced and to possess physiological activities similar to the normal products. The commoner examples together with the most frequent sites of origin of the associated tumours are shown in Table 1 . Other materials with insulin-like, thyrotrophin-like and hypercalcemic properties, together with renin, the prostaglandins and the various principles associated with the carcinoid syndrome are also known to be produced.
While the commonest syndrome is due to erythropoietin production chiefly by renal tumours, most attention has focused upon the various syndromes with which bronchogenic carcinomas are associated. Approximately 10% of bronchial tumours cause metabolic and/or 1967 ). In addition to bronchial tumours, the syndrome is caused principally by tumours of the thymus or of the islets of Langerhans, carcinoid tumours and medullary carcinoma of the thyroid, although a wide variety of structural types of tumour at many other sites have also been implicated (Symington 1969) . The oat cell carcinoma is the commonest type of bronchial tumour which, with the thymic tumours of the 'epithelial type', appears to carry a poorer prognosis than such tumours unassociated with ACTH production (Ross 1965) . Many have metastasized at the time of initial presentation.
The large amounts of ACTH produced by these tumours result in a highly characteristic type of bilateral adrenocortical hyperplasia. The adrenal glands are markedly enlarged, mostly weighing between 14 and 16 g, although weights in excess of 20 g are not uncommon. Microscopically, the cortex is considerably broader than normal and consists of columns of hyper-trophied compact cells extending from the medulla to the capsule (Fig 1) . Islands of large clear lipid-laden cells may occur throughout the cortex or form peripheral caps to the compact cell columns. The zona glomerulosa has a focal distribution and is not prominent.
The adrenal cortex of patients given the drug 2-aminoglutethimide, in an attempt to diminish the clinical and metabolic features by inhibiting the conversion of cholesterol to pregnenolone, exhibits accumulation of lipid in the adrenal cells of the inner aspects of the cortex (Fig 2) .
If the drug is withdrawn, the appearances quickly revert to the characteristic pattern of hyperplasia. Macroscopic or microscopic evidence of metastatic deposits of tumour are frequently detected in the cortex or medulla.
Most authors consider the weight and macroscopic features of the pituitary gland at autopsy to be normal in the ectopic ACTH syndrome. While the cellular features may likewise be normal (Prunty et al. 1963 ), Crooke's hyaline change of the basophils is inconstantly present (Symington 1969) . It is most frequently found with islet cell tumours, but its presence or absence appears to depend on the length of time the syndrome has been present. Other features including chromophobe and basophil adenomas, foci of basophil hyperplasia and metastases affecting the anterior or posterior lobes have also been described (Prunty et al. 1963 , Sayle et al. 1965 .
In almost all patients with ectopic ACTHsecreting tumours, at autopsy the pituitary content of ACTH is less than normal. Such a finding need not indicate reduced biosynthetic activity, as similar results were found at autopsy of patients with classical Cushing's syndrome and bilateral adrenocortical hyperplasia (Currie et al. 1963) .
The various tumours associated with this syndrome contain ACTH or a peptide with immunological, biological and physicochemical properties similar to those of 'normal' ACTH (Liddle 1968 ). Its production by tissue cultures of the tumours has also been demonstrated and recent studies of considerable diagnostic importance indicate that its in vivo secretion can be cyclic (Bailey 1971) . Although the plasma levels of ACTH are higher in this than in any other form of Cushing's syndrome, the amount of ACTH stored per unit mass by such lesions is small compared to the normal pituitary. It has been proposed as a result of examining oat cell and thymic carcinomas and bronchial adenomas that the ACTH is stored in cytoplasmic secretory granules (Corrin & McMillan 1970 , Kay & Willson 1970 , which bear some resemblance to the granules of islet cell and carcinoid tumours (Goldenberg et al. 1969 , Johnstone & Waisman 1971 . However, such
granules have yet to be proved as the locus of ACTH; indeed, they can be found in bronchial tumours without evidence of Cushing's syndrome. While this may appear to vitiate the role of the granules, it is worth observing that increased ACTH production and Crooke's hyaline changes in the pituitary basophils have been detected in the absence of overt signs and symptoms of Cushing's syndrome in patients with pulmonary carcinomas (Kennedy et al. 1964 , Hauger-Klevene 1968 .
Future studies must be directed towards elucidating the structure of ectopically produced ACTH. Although current evidence supports the view that it is of normal structure, some tumour extracts demonstrate dissociation of immunological and bioassayable ACTH activity (Liddle 1968 ). In addition, patients with pulmonary carcinomas can have hyperplastic adrenal glands at autopsy without evidence of Cushing's syndrome. High levels of an adrenal weight maintaining factor but no bioassayable ACTH were demonstrable in those tumour extracts (Marks et al. 1961 , Nichols & Gourley 1963 .
Ectopic ADHSyndrome
About 50 examples of hyponatremia due to the production of ADH by bronchogenic carcinoma have been described (Bartter & Schwartz 1967 , Omenn & Wilkins 1970 . Most, but not all, tumours have been of the oat cell type and are considered to carry a better prognosis than other histologically identical tumours unassociated with ADH formation (Ross 1965) . The biological and chemical methods employed to date suggest that tumour ADH is similar to 'normal' ADH and is present in tumours in much lower amounts per unit mass than in the posterior pituitary (Liddle 1968 , Lipscomb et al. 1968 ). The high plasma ADH levels attained in the syndrome seem to be responsible for the vacuolation of the hypothalamic nuclei and posterior pituitary cells found at autopsy and are interpreted as being due to depletion of their content ofendogenous ADH.
Ectopic Parathormone Syndrome
While the occurrence of hypercalcxemia with 'nonendocrine' tumours is most commonly associated with renal carcinomas, some 20 examples of parathormone production by bronchogenic carcinomas, usually of the squamous variety, have been recorded (Omenn & Wilkins 1970) . The hormone is considered to have a normal structure and is present in small amounts compared to parathyroid tissue (Sherwood et al. 1967) . No uniform pathology of the parathyroid glands is described in this syndrome; they have been considered to be atrophic, normal or even hyperplastic (Sommers 1968 ).
Ectopic Gonadotrophin Syndrome A few gonadotrophin-producing pulmonary carcinomas, mostly of the giant cell anaplastic type, have been described in men (Fusco & Rosen 1966 , Weintraub & Rosen 1971 . As with the other syndromes, the hormone content of the tumours is low when compared with that of the normal pituitary (Faiman et al. 1967) . Different trophic materials, including follicle stimulating hormone (FSH), luteinizing hormone (LH), human chorionic gonadotrophin and human chorionic somatomammotrophin, have been extracted from the tumours and found in elevated amounts in the plasma. Interstitial cell hyperplasia and spermatogenic arrest are seen in the testes of such patients, who also exhibit gynecomastia.
Functional and Structural Relationships Some of the tumours which can produce ACTH, such as those of the thymus and islets of Langerhans, carcinoid tumours and medullary carcinoma of the thyroid, possess light and electron morphological similarities to one another and to bronchogenic oat cell carcinomas (Cohen et al. 1960) . There is, in addition, evidence that each of these tumour types can also form a variety of other ectopic hormones in association with ACTH. These include melanocyte-stimulating hormone (MSH), ADH, parathormone, gastrin, glucagon, insulin, catecholamines, serotonin, its precursors and the kinins associated with the carcinoid syndrome (Liddle et al. 1965 , O'Neal et al. 1968 , Williams et al. 1968 ). Pearse (1969) has proposed the concept of a series of related polypeptide hormone-producing cells (APUD series) of which pheochromocytes, C-cells of the thyroid, the islets of Langerhans, enterochromaffin and some pituitary cells are examples. These cells share structural and functional similarities and produce most of the hormones associated with the para-endocrine syndrome. Consequently, the APUD cells may all arise from a common embryological precursor stem cell.
While the morphological and functional similarities of the oat cell carcinoma and the various other tumours producing the paraendocrine syndrome to each other and to the APUD cell series support the contention that all may have a similar origin, the variety of other structural types of bronchogenic carcinomas which can be associated with ectopic hormone production appears to argue against it. However, Willis (1967) in his extensive studies of bronchogenic carcinoma observed that variation in cell type and structure was frequent and that all these tumours were really examples of a single entity, namely bronchogenic carcinomas, the structural variations of which were often pleomorphic.
Thus, it is not unreasonable to postulate that a common mechanism and cell may be responsible for the origin of these ectopic hormone-producing tumours. The neuroectodermal cell has been proposed as the only candidate which could migrate to the various parts of the ectoderm and entoderm from which the organs with APUD cells or these tumours arise (Pearse 1969 , Weichert 1970 . While this is an attractive proposition, there is at present no concrete proof in its support. If such cells are scattered in these various sites, it will be important to ascertain if, under normal conditions, they are capable of forming these various hormones, albeit in trace amounts. If so, then the hormonal production by such tumours is not truly 'ectopic' secretion but represents retention rather than acquisition of secretory function.
Alternatively, the stem cell may have, initially, the enzymic potential to form all these hormones. Differentiation and specialization to produce one or one particular group of hormones may occur under the influence of the environment in which the cell finds itself (Weston 1970) . With tumour production, these environmental influences may be lost, and the other hormonal products then produced.
The para-endocrine syndrome is an exciting molecular pathological problem, the solution of which will depend upon improved understanding of the embryology, structure and function of the various normal and tumour cell types and detailed analyses of the hormonal products to ascertain their structure.
Some Clinical Aspects of the Para-endocrine Syndromes
This paper is concerned with some of the metabolic consequences of cancer to the host.
An unexpected relationship between endocrinology and oncology has become apparent over the past two decades with the gradual realization that cancer cells are capable of secreting polypeptide hormones which have biological properties indistinguishable from hormonal polypeptides produced by conventional endocrine patient with what he called 'the pluriglandular syndrome, the diabetes of bearded women', a woman who was obese, hirsute, bald and diabetic, who died and was found to have bilateral adrenal hyperplasia and also a carcinoma of the bronchus. The latter was regarded at the time as being purely coincidental but would now be recognized as the cause of her misfortunes because the tumour was secreting a corticotrophin resulting in stimulation of the adrenal cortex and the production of grossly excessive amounts of cortisol, with the metabolic consequences that follow from this.
The polypeptide hormones currently considered to be produced by tumours, the sites of the major primary cancers concerned, and their metabolic consequences, are summarized in Table 1 .
Clinical Significance
Apart from the academic interest of finding a cancer cell behaving as an endocrine organ, the clinical significance includes the production of symptoms that may add to those due to the cancer itself and make the patient's remaining days more miserable than they need be. Hypercalcmemia in particular can lead to very unpleasant abdominal colic, constipation and psychosis relieved by the administration of hydrocortisone. Water retention due to excess of vasopressin may lead to drowsiness and irritability and sometimes fits, often mistakenly ascribed to cerebral secondaries, cured by the administration of fludrocortisone. The Zollinger-Ellison syndrome is cured by the removal of a gastrin-secreting tumour.
Occasionally a patient is seen with carcinoma of the bronchus who is lethargic, hypotensive and pigmented and appears to have Addison's disease. Surprisingly, the plasma cortisol concentration is very high but urinary steroid excretion is very low. Here the degree of protein binding, presumably to peptides secreted by the cancer, has been elevated to such an extent that free (i.e. biologically active) cortisol circulating in plasma is virtually absent; such patients
